Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Melanomas in renal transplant recipients: a single- centre study (CROSBI ID 313811)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Borlinić, Tajana ; Knežević, Tamara ; Gellineo, Lana ; Franceschi, Maja ; Bukvić Mokos, Zrinka ; Bašić-Jukić, Nikolina Melanomas in renal transplant recipients: a single- centre study // Acta Dermatovenerologica Croatica, 25 (2017), 4; 281-281

Podaci o odgovornosti

Borlinić, Tajana ; Knežević, Tamara ; Gellineo, Lana ; Franceschi, Maja ; Bukvić Mokos, Zrinka ; Bašić-Jukić, Nikolina

engleski

Melanomas in renal transplant recipients: a single- centre study

Skin cancers are the most common malignancies in renal transplantrecipients, with squamous-cell and basal-cell cancers accounting for the majorityof all skin cancer cases. Melanoma is relatively rare in this group of patients.From 1973 to May 2017, out of 1889 patients who received allografts at our institution, 4 developed melanoma. After the mean follow-up of 11.5 months, 2patients died and 2 are still alive with functioning allografts. Malignancies werelocalized in the legs in both female patients, and in the neck and head in 1 malepatient each. Compared to the general population of Croatia, renal transplantrecipients from our cohort have 6.85 times higher risk for development of melanoma.Regular screenings and patient education are mandatory, especially inMediterranean countries.

skin cancer ; melanoma ; renal transplantation ; immunosuppression ; outcome

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

25 (4)

2017.

281-281

objavljeno

1847-6538

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Kliničke medicinske znanosti

Indeksiranost